Overview

Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Hydros-TA Joint Therapy for relief of pain due to OA of the knee. Hydros-TA is designed to provide fast acting and long lasting pain relief for up to six months with a single IA injection.
Phase:
Phase 3
Details
Lead Sponsor:
Carbylan Therapeutics, Inc.
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide